BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15789059)

  • 1. Selective induction of tumor-associated antigens in murine pulmonary vasculature using double-targeted adenoviral vectors.
    Everts M; Kim-Park SA; Preuss MA; Passineau MJ; Glasgow JN; Pereboev AV; Mahasreshti PJ; Grizzle WE; Reynolds PN; Curiel DT
    Gene Ther; 2005 Jul; 12(13):1042-8. PubMed ID: 15789059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity.
    Mahasreshti PJ; Kataram M; Wang MH; Stockard CR; Grizzle WE; Carey D; Siegal GP; Haisma HJ; Alvarez RD; Curiel DT
    Clin Cancer Res; 2003 Jul; 9(7):2701-10. PubMed ID: 12855650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus tumor targeting and hepatic untargeting by a coxsackie/adenovirus receptor ectodomain anti-carcinoembryonic antigen bispecific adapter.
    Li HJ; Everts M; Pereboeva L; Komarova S; Idan A; Curiel DT; Herschman HR
    Cancer Res; 2007 Jun; 67(11):5354-61. PubMed ID: 17545616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The flt-1 promoter for transcriptional targeting of teratocarcinoma.
    Bauerschmitz GJ; Nettelbeck DM; Kanerva A; Baker AH; Hemminki A; Reynolds PN; Curiel DT
    Cancer Res; 2002 Mar; 62(5):1271-4. PubMed ID: 11888889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer.
    Kaliberov SA; Kaliberova LN; Stockard CR; Grizzle WE; Buchsbaum DJ
    Mol Ther; 2004 Dec; 10(6):1059-70. PubMed ID: 15564138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
    Barker SD; Dmitriev IP; Nettelbeck DM; Liu B; Rivera AA; Alvarez RD; Curiel DT; Hemminki A
    Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system.
    Koch PE; Guo ZS; Kagawa S; Gu J; Roth JA; Fang B
    Mol Ther; 2001 Mar; 3(3):278-83. PubMed ID: 11273768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach.
    Brand K; Löser P; Arnold W; Bartels T; Strauss M
    Gene Ther; 1998 Oct; 5(10):1363-71. PubMed ID: 9930342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional targeting of adenovirus vectors with the squamous cell carcinoma-specific antigen-2 promoter for selective apoptosis induction in lung cancer.
    Oshikiri T; Miyamoto M; Hiraoka K; Shichinohe T; Kawarada Y; Kato K; Suzuoki M; Nakakubo Y; Kondo S; Dosaka-Akita H; Kasahara N; Katoh H
    Cancer Gene Ther; 2006 Sep; 13(9):856-63. PubMed ID: 16710347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient co-transduction of adenoviral vectors encoding carcinoembryonic antigen and survivin into dendritic cells by the CAR-TAT adaptor molecule enhance anti-tumor immunity in a murine colorectal cancer model.
    Kim HS; Kim CH; Park MY; Park JS; Park HM; Sohn HJ; Kim HJ; Kim SG; Oh ST; Kim TG
    Immunol Lett; 2010 Jun; 131(1):73-80. PubMed ID: 20211203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific transcriptional targeting of suicide gene therapy.
    Qiao J; Doubrovin M; Sauter BV; Huang Y; Guo ZS; Balatoni J; Akhurst T; Blasberg RG; Tjuvajev JG; Chen SH; Woo SL
    Gene Ther; 2002 Feb; 9(3):168-75. PubMed ID: 11859419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice.
    Dumortier J; Schönig K; Oberwinkler H; Löw R; Giese T; Bujard H; Schirmacher P; Protzer U
    Gene Ther; 2005 Apr; 12(8):668-77. PubMed ID: 15647761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific gene therapy directed to tumor angiogenesis.
    Varda-Bloom N; Shaish A; Gonen A; Levanon K; Greenbereger S; Ferber S; Levkovitz H; Castel D; Goldberg I; Afek A; Kopolovitc Y; Harats D
    Gene Ther; 2001 Jun; 8(11):819-27. PubMed ID: 11423929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo analysis of a genetically modified adenoviral vector targeted to human CD40 using a novel transient transgenic model.
    Izumi M; Kawakami Y; Glasgow JN; Belousova N; Everts M; Kim-Park S; Yamamoto S; Wang M; Le LP; Reynolds PN; Curiel DT
    J Gene Med; 2005 Dec; 7(12):1517-25. PubMed ID: 16170831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
    Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
    Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
    Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy.
    Crittenden M; Gough M; Chester J; Kottke T; Thompson J; Ruchatz A; Clackson T; Cosset FL; Chong H; Diaz RM; Harrington K; Alvarez Vallina L; Vile R
    Cancer Res; 2003 Jun; 63(12):3173-80. PubMed ID: 12810645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel system for mitigation of ectopic transgene expression induced by adenoviral vectors.
    Reynolds PN; Holmes MD; Adachi Y; Kaliberova L; Curiel DT
    Gene Ther; 2001 Aug; 8(16):1271-5. PubMed ID: 11509961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers.
    Fechner H; Haack A; Wang H; Wang X; Eizema K; Pauschinger M; Schoemaker R; Veghel R; Houtsmuller A; Schultheiss HP; Lamers J; Poller W
    Gene Ther; 1999 Sep; 6(9):1520-35. PubMed ID: 10490761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.